FDA Considers Additive to Detox Pig Feed from Sneaky Zearalenone
Published Date: 9/3/2025
Proposed Rule
Summary
Biomin GmbH asked the FDA to approve a new food additive that helps break down a harmful toxin called zearalenone in pig feed. This change aims to keep pigs healthier by reducing this toxin safely. If approved, farmers could start using this additive soon, making pig food safer without extra costs.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Proposal to Allow Enzyme in Swine Feed
The FDA received a petition to allow the enzyme zearalenone hydrolase to be added to swine feed at no less than 10 U/kg of complete feed (U = the five-fold enzymatic activity that hydrolyzes 1 µmol zearalenone per minute in a solution of 5 mg/L zearalenone). If approved, feed makers and pig farmers could legally use this enzyme in pig feed at that specified dose.
Reduces Harmful Zearalenone in Pigs
The petition says the additive helps break down the harmful toxin zearalenone in pig feed and aims to keep pigs healthier by reducing that toxin safely. This change is intended to improve animal health on farms by lowering zearalenone exposure in swine.
No Extra Feed Cost If Approved
The document states that if approved, farmers could start using the additive soon and that it would make pig feed safer without extra costs. That means, according to the petition summary, farmers would not face added feed costs when adopting the enzyme.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13047 — Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-13778 — Medical Device User Fee Amendments; Public Meeting; Request for Comments
The FDA is planning a public meeting on August 5, 2026, to talk about renewing fees that medical device makers pay to help speed up device reviews from 2028 to 2032. This affects companies making medical devices and could impact how much they pay and how fast their products get approved. The current fee program ends in September 2027, so the FDA wants your thoughts before finalizing new rules and fees.
2026-13716 — New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
The FDA just updated the rules for new animal drugs, approving several new and generic medicines for pets and farm animals from early 2026. These changes help keep animal treatments safe and effective, and the updates take effect right away on July 7, 2026. If you’re a drug maker or animal caretaker, these approvals and sponsor changes could impact what medicines are available and when.
2026-13616 — Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The FDA is officially pulling the plug on 34 drug approvals because the companies stopped selling these medicines. This change kicks in on August 5, 2026, and it mainly affects drug makers like Endo Operations and Pfizer. No money penalties here—just a clean break, but companies can ask to reapply if they want to bring the drugs back.
2026-13534 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings
The FDA is asking for public feedback on how it collects information for formal hearings and administrative rules. This affects businesses and people who interact with the FDA, with no new costs but a chance to improve paperwork processes. Comments are due by August 5, 2026, so don’t miss your chance to weigh in!
2026-13519 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical Devices
The FDA is asking for public feedback on their paperwork rules for approving the most important and risky medical devices, like life-support machines. This review helps keep devices safe and effective before they hit the market. If you have thoughts, you’ve got until August 5, 2026, to share them—no cost changes, just a check-in on the info they collect.
Previous / Next Documents
Previous: 2025-16836 — State Approving Agency Jurisdiction Rule
The VA is updating rules to clearly explain what counts as independent study, distance learning, and resident learning, plus adding a new term called standard curriculum. This helps State Approving Agencies know exactly which courses they oversee, especially for online classes. These changes affect schools and veterans using education benefits and aim to make things clearer without extra costs or delays.
Next: 2025-16866 — Disclosure of Returns and Return Information in Connection With Written Contracts or Agreements for the Acquisition of Property or Services for Tax Administration Purposes; Withdrawal
The government decided to cancel a plan that would have let the State Department share tax info with its contractors to help with passport issues tied to unpaid taxes. This change means no new rules or costs will happen, and people dealing with passport problems won’t see any new info-sharing. Basically, the plan was dropped because it wasn’t needed after all.